TFF Pharmaceuticals Receives Approval from Health Canada to Enter Human Clinical Trials for Inhaled Formulation of Niclosamide to Treat COVID-19 Read more
Pfizer And BioNTech To Provide U.S. Government An Additional 50 Million Pediatric Doses Of COVID-19 Vaccine To Support Further Preparedness For Future Needs Read more
Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid Tumors Read more
Sorrento Announces Encouraging Results From Two Phase 2 Studies of Abivertinib For Treatment Of Hospitalized Severe COVID-19 Patients Read more